Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issues

Everolimus-induced OU is a frequent, recurrent and sometimes harmful complication. A dose effect relationship is displayed. Its daily management remains challenging. OU represents a key issue in the compliance of mTOR inhibitors.